MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, will launch the NovaSure® V5 global endometrial ablation (GEA) device at the American Association ...

“Since its launch over 20 years ago, we have constantly listened to our customers’ feedback, which has driven continuous design improvements for NovaSure,” said Jan Verstreken, Group President, ...

Please provide your email address to receive an email when new articles are posted on . Reintervention rates were higher for hysteroscopic myomectomy, uterine artery embolization and endometrial ...

Surgical treatment options currently include hysteroscopic myomectomy, abdominal myomectomy, laparoscopic myomectomy, and endometrial ablation. Many women with fibroids can be treated with these ...

Please provide your email address to receive an email when new articles are posted on . Live birth rates were similar for women with uterine fibroids who underwent radiofrequency ablation or ...

BERKELEY, Calif.--(BUSINESS WIRE)--Channel Medsystems, Inc., a medical device company whose mission is to empower every woman to take control of her health journey, today announced that the first ...

On March 20, Dr. Mitch Dizon, a subspecialist in Minimally Invasive Gynecologic Surgery at Erlanger Women’s Health, performed the region’s first laparoscopic radiofrequency ablation surgery for ...

For many women experiencing symptoms caused by uterine fibroids the only option for relief was a hysterectomy and that created its own kind of pain for women still wanting to have children. Now ...

CMS has approved ASCs as a site of service for transcervical uterine fibroid ablation — a minimally invasive procedure for symptomatic uterine fibroids that can be performed with the Sonata System ...

Over the last 20 years, the NovaSure system has built a trusted legacy in GEA. The NovaSure device first received FDA approval in 2001, and by 2018 the NovaSure procedure had been used to treat over 3 ...